Product
DaTSCAN
1 clinical trial
1 indication
Indication
Healthy SubjectsClinical trial
A Phase 1, Non-randomised, Noncomparative, Open-label Study to Assess the Safety, Biodistribution, and Internal Radiation Dosimetry of a Single Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy VolunteersStatus: Completed, Estimated PCD: 2021-09-04